What are the trade names of the stimulant medications (methylphenidate and amphetamine) used as first‑line therapy for an 8‑year‑old child with attention‑deficit/hyperactivity disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Trade Names of First-Line ADHD Stimulant Medications

For an 8-year-old child with ADHD, the first-line stimulant medications are methylphenidate and amphetamine products, available under numerous brand names including Ritalin, Concerta, Focalin, Adderall, Vyvanse, and Dexedrine.

Methylphenidate Trade Names

Methylphenidate is available in multiple formulations 1:

Immediate-Release Formulations:

  • Ritalin (immediate-release tablets)
  • Methylin (immediate-release tablets and oral solution)

Extended-Release Formulations:

  • Concerta (once-daily extended-release)
  • Ritalin LA (long-acting capsules)
  • Ritalin SR (sustained-release tablets)
  • Metadate CD (extended-release capsules)
  • Metadate ER (extended-release tablets)
  • Quillivant XR (extended-release oral suspension)
  • Quillichew ER (extended-release chewable tablets)
  • Daytrana (transdermal patch)
  • Jornay PM (evening-dosed extended-release)
  • Adhansia XR (extended-release capsules)
  • Aptensio XR (extended-release capsules)

Dexmethylphenidate (active D-isomer) Formulations:

  • Focalin (immediate-release)
  • Focalin XR (extended-release)

Amphetamine Trade Names

Amphetamine products are available in several formulations 2:

Mixed Amphetamine Salts:

  • Adderall (immediate-release mixed amphetamine salts)
  • Adderall XR (extended-release mixed amphetamine salts)
  • Mydayis (extended-release mixed amphetamine salts)

Dextroamphetamine:

  • Dexedrine (immediate-release)
  • Dexedrine Spansules (extended-release)
  • ProCentra (oral solution)
  • Zenzedi (immediate-release tablets)

Lisdexamfetamine (Prodrug):

  • Vyvanse (extended-release capsules and chewable tablets) - This is a prodrug that requires oral administration and enzymatic conversion to become active d-amphetamine 3, 4

Clinical Context

The 2019 AAP guideline establishes methylphenidate and amphetamine products as first-line pharmacologic therapy for school-aged children with ADHD 5. Extended-release formulations are generally preferred in clinical practice to avoid medication administration during school hours and to minimize side effects from rapid serum concentration fluctuations 3, 4. Recent evidence suggests amphetamine products may have moderately greater efficacy than methylphenidate products 6, though both medication classes demonstrate significant benefit when properly titrated 7, 8.

References

Related Questions

What are the limitations and guidelines for prescribing Attention Deficit Hyperactivity Disorder (ADHD) medications, such as methylphenidate and Adderall (amphetamine-based medications), to pediatric patients?
What are the differences between amphetamine and methylphenidate for treating ADHD, including indications, dosing, efficacy, side effects, and monitoring?
In a 14-year-old with attention-deficit/hyperactivity disorder (ADHD) taking immediate-release methylphenidate (Ritalin) 15 mg at 8 am and 12 pm who continues to have difficulty concentrating and focusing, how should the medication regimen be adjusted or what additional management strategies are recommended?
In a 5‑year‑old boy with ADHD, should treatment begin with Adderall (amphetamine) or methylphenidate?
What is the best short-acting stimulant to add to an existing once-daily lisdexamfetamine (Vyvanse) regimen?
For a pediatric patient with adult body weight, should the initial omeprazole dose be 20 mg or 40 mg once daily?
Is quercetin present in grapefruit?
What is the starting dose of Caplyta (lumateperone) for bipolar disorder and how likely is it to cause akathisia?
What is the appropriate treatment for patellar bursitis?
What is the recommended duration of colchicine therapy for acute and recurrent pericarditis, and how should the dose be adjusted in patients with renal impairment?
In a patient with normal renal function, which antibiotics should be given, including dose, frequency, and duration?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.